| VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient EW Johnston, E Bonet-Carne, U Ferizi, B Yvernault, H Pye, D Patel, ... Radiology 291 (2), 391-397, 2019 | 66 | 2019 |
| INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of … E Johnston, H Pye, E Bonet-Carne, E Panagiotaki, D Patel, M Galazi, ... BMC cancer 16, 1-11, 2016 | 54 | 2016 |
| Antibody-directed phototherapy (ADP) H Pye, I Stamati, G Yahioglu, MA Butt, M Deonarain Antibodies 2 (2), 270-305, 2013 | 48 | 2013 |
| Apparatus for histological validation of in vivo and ex vivo magnetic resonance imaging of the human prostate RM Bourne, C Bailey, EW Johnston, H Pye, S Heavey, H Whitaker, B Siow, ... Frontiers in oncology 7, 255782, 2017 | 36 | 2017 |
| Development of photodynamic antimicrobial chemotherapy (PACT) for Clostridium difficile L De Sordi, MA Butt, H Pye, D Kohoutova, CA Mosse, G Yahioglu, ... PLoS One 10 (8), e0135039, 2015 | 28 | 2015 |
| An optimised saliva collection method to produce high-yield, high-quality RNA for translational research R Sullivan, S Heavey, DG Graham, R Wellman, S Khan, S Thrumurthy, ... PloS one 15 (3), e0229791, 2020 | 24 | 2020 |
| VERDICT MRI validation in fresh and fixed prostate specimens using patient‐specific moulds for histological and MR alignment C Bailey, RM Bourne, B Siow, EW Johnston, M Brizmohun Appayya, ... NMR in Biomedicine 32 (5), e4073, 2019 | 24 | 2019 |
| Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models AM de Pinillos Bayona, JH Woodhams, H Pye, RA Hamoudi, CM Moore, ... Cancer letters 393, 68-75, 2017 | 24 | 2017 |
| Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate MA Butt, H Pye, RJ Haidry, D Oukrif, I Puccio, M Gandy, HW Reinert, ... Oncotarget 8 (15), 25080, 2017 | 21 | 2017 |
| Cathepsin B-degradable, NIR-responsive nanoparticulate platform for target-specific cancer therapy SP Tarassoli, AM de Pinillos Bayona, H Pye, CA Mosse, JF Callan, ... Nanotechnology 28 (5), 055101, 2017 | 19 | 2017 |
| Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth E Scott, K Hodgson, B Calle, H Turner, K Cheung, A Bermudez, ... Oncogene 42 (12), 926-937, 2023 | 17 | 2023 |
| A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy H Pye, MA Butt, HW Reinert, A Maruani, JPM Nunes, JS Marklew, ... Photochemical & Photobiological Sciences 15, 1227-1238, 2016 | 15 | 2016 |
| Evaluation of PSA and PSA density in a multiparametric magnetic resonance imaging-directed diagnostic pathway for suspected prostate cancer: the INNOVATE trial H Pye, S Singh, JM Norris, LM Carmona Echeverria, V Stavrinides, A Grey, ... Cancers 13 (8), 1985, 2021 | 14 | 2021 |
| Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression H Pye, MA Butt, L Funnell, HW Reinert, I Puccio, SUR Khan, S Saouros, ... Oncotarget 9 (33), 22945, 2018 | 14 | 2018 |
| Avoiding unnecessary biopsy after multiparametric prostate MRI with VERDICT analysis: The INNOVATE study S Singh, H Rogers, B Kanber, J Clemente, H Pye, EW Johnston, T Parry, ... Radiology 305 (3), 623-630, 2022 | 13 | 2022 |
| Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer S Luszczak, BS Simpson, U Stopka-Farooqui, VK Sathyadevan, ... Scientific reports 10 (1), 14380, 2020 | 13 | 2020 |
| The oncological relevance of fragile sites in cancer BS Simpson, H Pye, HC Whitaker Communications Biology 4 (1), 567, 2021 | 11 | 2021 |
| Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates J Olivier, V Stavrinides, J Kay, A Freeman, H Pye, Z Ahmed, ... The Prostate 78 (16), 1229-1237, 2018 | 11 | 2018 |
| Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI M Palombo, V Valindria, S Singh, E Chiou, F Giganti, H Pye, HC Whitaker, ... Scientific Reports 13 (1), 2999, 2023 | 10 | 2023 |
| Genetic alterations in the 3q26. 31-32 locus confer an aggressive prostate cancer phenotype BS Simpson, N Camacho, HJ Luxton, H Pye, R Finn, S Heavey, J Pitt, ... Communications Biology 3 (1), 440, 2020 | 8 | 2020 |
